Table 3.
Variable | HR | (95% CI) | P value | HR | (95% CI) | P value |
---|---|---|---|---|---|---|
Univariable | Multivariable | |||||
Tumor size | ||||||
≤20 vs >20 | 1,49 | (1.14 - 1.96) | 0,004 | 1,41 | (0.94 - 2.12) | 0,094 |
NHG | ||||||
1, 2 vs 3 | 1,61 | (1.14 - 2.28) | 0,007 | 1,65 | (1.07 - 2.53) | 0,023 |
Nodal metastasis | ||||||
- vs + | 1,51 | (1.13 - 2.02) | 0,006 | 2,01 | (1.30 - 3.10) | 0,002 |
ER | ||||||
- vs + | 0,42 | (0.27 - 0.63) | 0,000 | 0,57 | (0.34 - 0.97) | 0,038 |
CD3 | ||||||
low vs high | 2,34 | (1.40 - 3.91) | 0,001 | 1,39 | (0.77 - 2.50) | 0,28 |
FOXP3 | ||||||
low vs high | 1,64 | (1.39 - 2.37) | 0,008 | 1,72 | (1.14 - 2.59) | 0,010 |
Abbreviations: HR hazard ratio, CI confidential interval, NHG Nottingham histologic grade, ER estrogen receptor, PR progesterone receptor. CD3 indicates infiltration level of T lymphocytes (low 0, 1, 2 vs high 3) in primary tumor. FOXP3 indicates infiltration level of regulatory T lymphocytes (low 0 vs high 1, 2, 3). Spearman correlation, two-tailed P value. Bold indicates P value < 0.05